CLASS II ONGOING Device recall · Reported 28 Oct 2026 · FDA Enforcement Report

Metatarsophalangeal (MTP) Implant is a sterile recalled by restor3d

restor3d is recalling Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, distributed nationwide in the US. The recall was initiated on 4 Sep 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Model: 1103-161620 UDI: 00840097505244 Lot: A02979
Quantity recalled16

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0264-2027
FDA event ID
99940
Recalling firm
restor3d, Durham, NC
Classification
Class II
Status
Ongoing
Recall initiated
4 Sep 2026
FDA classified
22 Oct 2026
Reported
28 Oct 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Device type
Medical Software

Timeline

4 Sep 2026Recall initiated by company
22 Oct 2026Classified by FDA+48 days
28 Oct 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Generic Name: restor3d MTP Implant Generic Name: MTP Implant Model/Catalog Number: 1103-161620 Software Version: None Product Description: The restor3d Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, available in varied articulating surface coverages. The restor3d MTP implant is designed to replace the damaged articulating surface of the first metatarsal distal head. The device is intended for the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head. This implant can also be used in the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The implant is a single use product intended to be press fit, with optional use of bone cement. The restor3d MTP Implant is comprised of a single laser powder bed fusion (LPBF) printed cobalt-chromium alloy (Co28Cr6Mo) part. The external surface of the implant that is intended to be in contact with the phalanx is mirror polished. Component: Not a component

Where it was distributed

U.S. Nationwide distribution in the states of FL, IL, NC, PA, SC, and TX.

Nationwide FloridaIllinoisNorth CarolinaPennsylvaniaSouth CarolinaTexas

Questions about this recall

Why was it recalled?

Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.

Which lots are affected?

Lot Code: Model: 1103-161620 UDI: 00840097505244 Lot: A02979

Where was it sold?

U.S. Nationwide distribution in the states of FL, IL, NC, PA, SC, and TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 3 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from restor3d

All 6

Other Medical Software recalls

All 935